Pyrithione Zinc

CHEMBL1200471 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
317.7 g/mol
LogP
Phase
4

Pyrithione zinc is a coordination complex of zinc and pyrithione with broad-spectrum antifungal and antibacterial activity that acts by disrupting membrane proton gradients and inhibiting key metabolic enzymes in Malassezia and other microorganisms. It is widely used in over-the-counter shampoos for dandruff and seborrheic dermatitis treatment, and in topical preparations for various dermatological conditions.

Peso Molecular

317,7000 g/mol

TPSA

52,90 Ų

Mecanismo de Ação

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

[O-][n+]1ccccc1[S-].[O-][n+]1ccccc1[S-].[Zn+2]

InChI

InChI=1S/2C5H5NOS.Zn/c2*7-6-4-2-1-3-5(6)8;/h2*1-4,8H;/q;;+2/p-2

Molecular Formula

C10H8N2O2S2Zn

HBD / HBA

- / 4

Ligações Rotacionáveis

2

Átomos Pesados

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

Pyrithione zinc is a coordination complex of zinc and pyrithione with broad-spectrum antifungal and antibacterial activity that acts by disrupting membrane proton gradients and inhibiting key metabolic enzymes in Malassezia and other microorganisms. It is widely used in over-the-counter shampoos for dandruff and seborrheic dermatitis treatment, and in topical preparations for various dermatological conditions.

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Yes, Pyrithione Zinc is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200471. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 26041. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.